BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-driven drug development company leveraging artificial intelligence (AI) and machine learning, has officially entered the commercial phase…
September 25, 2025
July 21, 2025
RedHill Biopharma Shares up 75% After Securing FDA Backing for Novel Crohn’s Disease Therapy RHB-204
RedHill Biopharma (RDHL) has received positive guidance from the U.S. Food and Drug Administration on its planned clinical pathway for RHB-204, a next-generation oral therapy…